167 related articles for article (PubMed ID: 11785112)
1. [Gene therapy of tumors, state of the art and prospects].
Lollini PL
Pathologica; 2001 Dec; 93(6):625-30. PubMed ID: 11785112
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for ovarian cancer (review).
Wolf JK; Jenkins AD
Int J Oncol; 2002 Sep; 21(3):461-8. PubMed ID: 12168087
[TBL] [Abstract][Full Text] [Related]
3. [Prostate cancer gene therapy].
Nasu Y; Kumon H
Nihon Rinsho; 2005 Feb; 63(2):335-8. PubMed ID: 15714988
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in gene-directed enzyme prodrug therapy (GDEPT) for cancer.
Niculescu-Duvaz I; Cooper RG; Stribbling SM; Heyes JA; Metcalfe JA; Springer CJ
Curr Opin Mol Ther; 1999 Aug; 1(4):480-6. PubMed ID: 11713763
[TBL] [Abstract][Full Text] [Related]
6. [Gene therapy of malignant tumors].
Hauses M; Schackert HK
Zentralbl Chir; 2000; 125 Suppl 1():41-6. PubMed ID: 10929646
[TBL] [Abstract][Full Text] [Related]
7. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
Määttä AM; Tenhunen A; Pasanen T; Meriläinen O; Pellinen R; Mäkinen K; Alhava E; Wahlfors J
Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834
[TBL] [Abstract][Full Text] [Related]
8. Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy.
Ketola A; Määttä AM; Pasanen T; Tulimäki K; Wahlfors J
Int J Mol Med; 2004 May; 13(5):705-10. PubMed ID: 15067374
[TBL] [Abstract][Full Text] [Related]
9. Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancer.
Ayala G; Satoh T; Li R; Shalev M; Gdor Y; Aguilar-Cordova E; Frolov A; Wheeler TM; Miles BJ; Rauen K; Teh BS; Butler EB; Thompson TC; Kadmon D
Mol Ther; 2006 Apr; 13(4):716-28. PubMed ID: 16480930
[TBL] [Abstract][Full Text] [Related]
10. TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo.
Pasanen T; Hakkarainen T; Timonen P; Parkkinen J; Tenhunen A; Loimas S; Wahlfors J
Int J Mol Med; 2003 Oct; 12(4):525-31. PubMed ID: 12964030
[TBL] [Abstract][Full Text] [Related]
11. Cancer gene therapy steadily advances.
Brower V
J Natl Cancer Inst; 2008 Sep; 100(18):1276-8. PubMed ID: 18780858
[No Abstract] [Full Text] [Related]
12. Gene therapy developments for pancreatic cancer.
Bhattacharyya M; Lemoine NR
Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):285-98. PubMed ID: 16549328
[TBL] [Abstract][Full Text] [Related]
13. Adenoviral strategies for the gene therapy of cancer.
Relph KL; Harrington KJ; Pandha H
Semin Oncol; 2005 Dec; 32(6):573-82. PubMed ID: 16338423
[TBL] [Abstract][Full Text] [Related]
14. [Gene therapy for colorectal cancer].
Nakamura S; Kaibara N
Nihon Rinsho; 2001 Jan; 59(1):94-7. PubMed ID: 11197870
[TBL] [Abstract][Full Text] [Related]
15. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
Janousková O; Síma P; Kunke D
Int J Oncol; 2003 Mar; 22(3):569-77. PubMed ID: 12579310
[TBL] [Abstract][Full Text] [Related]
16. Assignment of 1H nuclear magnetic resonance visible polyunsaturated fatty acids in BT4C gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death.
Griffin JL; Lehtimäki KK; Valonen PK; Gröhn OH; Kettunen MI; Ylä-Herttuala S; Pitkänen A; Nicholson JK; Kauppinen RA
Cancer Res; 2003 Jun; 63(12):3195-201. PubMed ID: 12810648
[TBL] [Abstract][Full Text] [Related]
17. [Gene therapy vector: adenovirus vector].
Saito I
Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1798-805. PubMed ID: 9279115
[No Abstract] [Full Text] [Related]
18. [In vitro model for the suicide gene therapy of AFP-producing gastric cancer using HSVtk gene under control of AFP promoter].
Nakaya H
Hokkaido Igaku Zasshi; 2003 May; 78(3):203-9. PubMed ID: 12795172
[No Abstract] [Full Text] [Related]
19. Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors.
Xu F; Li S; Li XL; Guo Y; Zou BY; Xu R; Liao H; Zhao HY; Zhang Y; Guan ZZ; Zhang L
Cancer Gene Ther; 2009 Sep; 16(9):723-30. PubMed ID: 19363470
[TBL] [Abstract][Full Text] [Related]
20. Parvovirus vectors: use and optimisation in cancer gene therapy.
Blechacz B; Russell SJ
Expert Rev Mol Med; 2004 Jul; 6(16):1-24. PubMed ID: 15387896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
